Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-312-8 | CAS number: 461-58-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Two oral acute toxicity studies similar to OECD 401 but with a low level of documentation and no specifications of the
test compound are available. Both indicate DCD to be practical nontoxic in rats. One inhalation study similar to OECD 403 shows DCD to be practical nontoxic in rats when applied at the highest achievable concentration of 259 mg/m3 for 4h. One dermal acute toxicity limit test equivalent to OECD 402 shows no toxic effect in rabbits at a limit dose of in 2000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1982
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not specified
- GLP compliance:
- not specified
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- No data
- Route of administration:
- oral: gavage
- Vehicle:
- other: edible oil
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): 2 ml
- total exposure duration: 1 and 5 days, respectively - Doses:
- - 7 g/kg body weight (Stomach tube, single treatment)
- 1 g/kg body weight (stomach tube, treatment for five consecutive days) - No. of animals per sex per dose:
- - 7 g/kg dose group: three rats were used, sex not specified
- 1 g/kg dose groupfive rats were used, sex not specified - Control animals:
- no
- Details on study design:
- No details reported
- Statistics:
- No statistics reported
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 7 000 mg/kg bw
- Mortality:
- No
- Clinical signs:
- other: - 7 g/kg dose group: no harmful effects, except for a slight weight loss during treatment, were observed on any rats. - 1 g/kg dose group: no clinical signs
- Gross pathology:
- No data
- Other findings:
- No data
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Dicyandiamide is practically nontoxic when administered orally in rats at doses of 1 g/kg bw (treatment for 5 consecutive days) and 7 g/kg bw (single dose).
- Executive summary:
In an acute oral toxicity study, groups of 3 and 5 rats were given oral doses of Dicyandiamide at 7000 mg/kg (vehicle: peanut oil) bw and 1000 mg/kg bw (vehicle: edible oil), respectively. The 7000 mg/kg bw dose was administered as one single dose. Rats which received the 1000 mg/kg bw dose were treated for 5 consecutive days.
No harmful effects, except for a slight weight loss during treatment in the 7000 mg/kg bw dose group, were observed on any rats.
Oral LD0 > 7000 mg/kg bw
Dicyandiamide is practically nontoxic based on the LD0 in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1977
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not specified
- GLP compliance:
- not specified
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Central Institute for Nutrition and Food Research
- Age at study initiation: young adults
- Weight at study initiation: males: 204-240 g; females: 85-125 g
- Fasting period before study: yes (overnight)
- Housing: screen-bottomed stainless steel cages in a well-ventilated room
- Diet: stock diet ad libitum
- Water: tap water ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23-25 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 33 % (w/v)
- Amount of vehicle (if gavage): 30 ml/kg bw (equivalent to 10 g test material/kg bw) - Doses:
- 10 g/kg body weight
- No. of animals per sex per dose:
- 10 animals per sex per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes - Statistics:
- The LD50 was calculated according to th emethod of Weil (Bioetrics 8 (1952) 249-263).
- Preliminary study:
- No data
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 10 000 mg/kg bw
- Mortality:
- No deaths occurred.
- Clinical signs:
- other: Within a few hours after treatment the rats showed sluggishness and humpback behaviour. Slight diarrhoea was frequently observed. These phenomena had dissappeared after 20 hours. The rats looked quite healthy during the rest of the observation period.
- Gross pathology:
- Macroscopic examinations of the survivors at autopsy did not revea any treatment-related gross alterations.
- Other findings:
- No other findings reported.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Dicyandiamide is practically nontoxic when administered orally in rats at a dose of 10 g/kg bw.
- Executive summary:
In an acute oral toxicity study (similar to OECD 401, limit test), groups of 10 fasted young adult albino rats (Wistar) of both sexes (10 animals per group) were given Dicyandiamide as 33 % aqueous suspension at a single dose of 10000 mg/kg bw and observed for 14 days.
Oral LD50: Males > 10000 mg/kg bw; Females > 10000 mg/kg bw
All animals survived to the scheduled sacrifice. There were no in-life observations indicating treatment related systemic effects. At necropsy, no deviations from normal morphology were found in all animals. Dicyandiamide is practically non-toxic based on the LD50 in rats.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January - November 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- no information on body weight changes, no raw data reported
- GLP compliance:
- no
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 8 weeks
- Weight at study initiation: males ca. 195 g, females ca. 131 g
- Diet (e.g. ad libitum): stock diet
- Water (e.g. ad libitum): tap water
- Housing: wire screen cages
- observation period: 14 days - Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure chamber volume: 1.5 m³
- Method of holding animals in test chamber: animals were housed in wire screen cages
- Source and rate of air: filtered air, flow rate: 1m³/h
- System of generating particulates/aerosols: the powder was continuously dispersed in air by means of a "Wright" Dust Feed Mechanism at a rate of 6g/m³
TEST ATMOSPHERE
- Brief description of analytical method used: particle size determinations and counts were carried out in samples taken from the atmosphere in the chamber with a cascade impactor
- Particle size distribution: 99 % particke size range of 0.6 - 2.4 µm
- Concentration in air: 259 mg/m³ (maximum attainable concentration)
- Determination of concentration: gravimetrically by passing measured amounts of chamber air through glass fibre filters
- Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Determination of concentration: gravimetrically by passing measured amounts of chamber air through glass fibre filters
- Duration of exposure:
- 4 h
- Concentrations:
- 259 mg/m³ (maximum attainable concentration)
- No. of animals per sex per dose:
- Five
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: no data
- Necropsy of survivors performed: no data
- Other examinations performed: mortality, signs of intoxication - Statistics:
- No data.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- > 259 mg/m³ air
- Exp. duration:
- 4 h
- Mortality:
- Mortality did not ocur either during exposure or during the subsequent 14-day observation period.
- Clinical signs:
- other: Signs of intoxication did not ocur either during exposure or during the subsequent 14-day observation period.
- Body weight:
- No data.
- Gross pathology:
- No data.
- Other findings:
- Other observations:
During the first quarter of an hour of the exposure period the rats showed slight restlessness; during the remaining part of the exposure period they were asleep. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- As a four-hour exposure of rats to a dispersion of Dicyandiamid at a maximum attainable concentration of 259 mg/m³ of air did not cause mortality or any noticeable deleterious effects, it can be concluded that the powder has a very low acute inhalation toxicity. It is not likely, therefore, that the substance at concentrations up to 259 mg/m³ will present acute inhalation hazard to man.
- Executive summary:
The aim of this study was to determine the 4 -hour LC50 value of Dicyandiamid. Each five male and female rats were exposed to the test atmosphere generated by dispersing the powder continuously in air by means of a "Wright" Dust Feed Mechanism at a rate of 6 g/m³ for four hours (whole-body exposure) at an actual concentration of 259 mg/m³ (maximum attainable concentration).
The animals were observed for mortality and signs of intixication during exposure and daily thereafter for 14 days. Particle determination and counts in air samples revealed a 99 % particle size range of 0.6 - 2.4 µm.
The four-hour exposure of the rats to a dispersion of Dicyandiamid at a maximum attainable concentration of 259 mg/m³ of air did not cause mortality or any noticeable deleterious effects, it can be concluded that the powder has a very low acute inhalation toxicity. It is not likely, therefore, that the substance at concentrations up to 259 mg/m³ will present acute inhalation hazard to man.
The acute inhalation (4 hour) LC50 for Dicyandiamid in the rat is higher than 259 mg/m³.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 259 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- December 1984 - January 1985
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- not specified
- GLP compliance:
- no
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hazelton Dutchland, Inc., Denver, Pennsylvania
- Weight at study initiation: males: 2099 - 2454 g; females: 2093 - 2446 g
- Housing: individually in elevated wire-mesh cages
- Diet (ad libitum): commercial rabbit ration (Purina Lab Rabbit Chow)
- Water (ad libitum): tap water
- Acclimation period: minimum -> one week prior to initiation of treatment - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: back of rabbits, hair was closely clipped; skin was left intact
- Type of wrap if used: nonabsorbent binder composed of rubber damming
REMOVAL OF TEST SUBSTANCE
- Washing (if done): exposure sites were wiped with water
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg/kg bw
- Constant volume or concentration used: yes
- For solids, paste formed: no - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- Five
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations for signs of toxic and pharmacologic effects: immediately after dosing, at one and four hours postdose, and once daily thereafter for fourteen consecutive days; mortality/moribundity was recorded twice daily
- Individual body weights were recorded prior to treatment, on Day 7 and at death or termination
- Necropsy of survivors performed: yes
- Other examinations performed: dermal responses were graded and scored on Days 1, 3, 7, 10, and 14 according to the system of Draize (1959) - Statistics:
- No data
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No mortality occured during the study.
- Clinical signs:
- other: All animals appeared normal throughout the study.
- Gross pathology:
- No observable gross pathology was noted in any animal at necropsy.
- Other findings:
- Dermal Irritation:
- Slight erythema (Grade 1) was noted in one male at day 1.
- All others appeared normal. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute dermal LD50 was estimated to be greater than 2000 mg/kg bw.
- Executive summary:
In an acute dermal toxicity study, groups of New Zealand White rabbits (5 animals per sex) were dermally exposed to Dicyandiamide for 24 hours at a dose of 2000 mg/kg bw (limit test). Animals then were observed for 14 days.
Dermal LD50: males > 2000 mg/kg bw; females > 2000 mg/kg bw; combined > 2000 mg/kg bw
No mortality occurred during the study. All animals occurred normal throughout the study. Slight erythema (Grade 1) occurred in one male on Day 1. All others appeared normal. No observable gross pathology was noted in any animal at necropsy. Dicyandimaid is relatively harmless based on the results of this study.
Reference
Table 1: Individual Body Weights, Acute Dermal Toxicity Study in Rabbits, 2000 mg/kg
Animal Number |
Body Weight - Grams |
||
|
Initiation |
Day 7 |
Day 14 |
Males |
|||
E37343 |
2445 |
2636 |
2830 |
E37344 |
2267 |
2449 |
2650 |
E37345 |
2454 |
2747 |
2870 |
E37346 |
2374 |
2717 |
2710 |
E37347 |
2099 |
2150 |
2300 |
Females |
|||
E37407 |
2120 |
2185 |
2370 |
E37408 |
2321 |
2287 |
2375 |
E37409 |
2446 |
2730 |
2960 |
E37410 |
2093 |
2132 |
2360 |
E37411 |
2446 |
2634 |
2480 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Two acute oral toxicity studies reported with a low level of documentation and no specifications of the test compound indicate DCD to be practical nontoxic in rats (LD0 = 7 g/kg bw; 10 g/kg bw). This finding is supported by a reliable inhalation study at the highest technically attainable concentration of 259 mg/m³. DCD shows no signs of toxicity in a dermal acute toxicity limit test at 2 g/kg bw.
These data meet the requirements of the REACH regulation. DCD is considered to be practical non-toxic in acute toxicity tests.
Justification for classification or non-classification
No mortalities or clinical signs were observed at appropriate dose levels.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.